Skip to content

Smith Andrew Alasdair Insider Trading -- Recent SEC Form 4 Transactions

Smith Andrew Alasdair (CIK 1309614) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-17). Recent activity: Buy MDCX (14,534 shares), Buy MDCX (735,294 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-11-17Medicus Pharma Ltd. (MDCX)Chief Operating OfficerBuy14,534$24,998
2026-09-08Medicus Pharma Ltd. (MDCX)Chief Operating OfficerBuy735,294$125,000

Source: SEC Form 4 filings · as of 2026-11-17